In mid-September, the U.S. Department of Justice (DOJ) announced that Abbott Laboratories will pay nearly $385 million to resolve allegations that it caused false claims to be submitted to federal and state programs.
The specific allegations, which initially were brought by three whistleblowers, are that Abbott failed to manufacture powdered infant formula at its St...